Parkinson's disease (PD) is a progressive, neurodegenerative disorder that primarily affects motor function, due to the loss of dopamine-producing cells in the substantia nigra. Understanding its pathophysiology, clinical presentation, diagnosis, and management is crucial for medical professionals.
The hallmark of PD is the degeneration of dopamine-producing neurons within the substantia nigra, leading to a decrease in striatal dopamine levels. This imbalance affects the normal functioning of the basal ganglia circuitry, resulting in the characteristic motor symptoms of PD.
The cardinal symptoms of PD include resting tremor, rigidity, bradykinesia, and postural instability. Non-motor symptoms such as cognitive impairment, mood disorders, sleep disturbances, and autonomic dysfunction can also occur, often preceding motor symptoms by years.
Diagnosis of PD is primarily clinical, based on the presence of characteristic motor symptoms and response to dopaminergic therapy. Neuroimaging techniques such as DaTscan can support the diagnosis but are not routinely used due to their high cost and limited availability.
Management of PD is symptomatic, with the primary aim to improve quality of life. Pharmacological treatment mainly involves dopamine replacement therapies. Non-pharmacological interventions include physical therapy, occupational therapy, and in advanced cases, deep brain stimulation.
PD is a complex neurodegenerative disorder with a multifaceted clinical presentation. A comprehensive understanding of its pathophysiology, clinical features, diagnosis, and management strategies is essential for optimal patient care. As medical professionals, we must stay abreast of the latest research developments to provide the best possible care to our patients with PD.
1.
TCL1A Protein Identified as Predictor of Blinatumomab Response in Relapsed B-ALL
2.
Health researchers discuss Medicaid cancer screening trends, best practices
3.
Taking Charge of Your Cancer Journey.
4.
On all CAR-T products, the FDA is calling for a new boxed warning.
5.
Nivolumab Regimen Achieves Durable PFS in Advanced Hodgkin's Lymphoma
1.
Innovative Intraoperative Therapies in Neurosurgical Oncology: Advancing Precision and Outcomes
2.
Breaking Down Leukocytoclastic Vasculitis: Causes, Symptoms and Treatment
3.
Getting to Know RDW and SD: How They Relate to Anemia, Inflammation, and More
4.
A Review on Genetic Predispositions and Clinical Advancements of Multiple Myeloma Cancer
5.
AI-Powered Rehabilitation: A Game Changer for Hemophilia Management
1.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
2.
International Cancer Conference
3.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
CDK4/6 Inhibitors in Extending Overall Survival in HR+/HER2- aBC Patients in Clinical Trial and Real World
2.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part II
3.
Navigating the Complexities of Ph Negative ALL - Part II
4.
Cost Burden/ Burden of Hospitalization For R/R ALL Patients
5.
Exploring the Hospitalization Burden in Refractory and Relapsed ALL
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation